141 related articles for article (PubMed ID: 31976596)
41. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
42. Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation.
Zhang H; Jin Y; Chen X; Jin C; Law S; Tsao SW; Kwong YL
Cancer Lett; 2007 Jan; 245(1-2):184-94. PubMed ID: 16488074
[TBL] [Abstract][Full Text] [Related]
43. [Expression of metastasis suppressor gene KAI1 in cervical carcinoma and infections of HPV16 E6, E7 and HPV18 E6/E7].
Ouyang YW; Pan XL; Peng ZL; Qu Y; Zhang HY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):410-3. PubMed ID: 18575327
[TBL] [Abstract][Full Text] [Related]
44. Human papillomavirus and human telomerase RNA component gene in cervical cancer progression.
Liu Y; Fan P; Yang Y; Xu C; Huang Y; Li D; Qing Q; Sun C; Zhou H
Sci Rep; 2019 Nov; 9(1):15926. PubMed ID: 31685833
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes.
Zhou J; Li B; Peng C; Wang F; Fu Z; Zhou C; Hong D; Ye F; Lü W; Xie X
Antiviral Res; 2013 May; 98(2):305-13. PubMed ID: 23523766
[TBL] [Abstract][Full Text] [Related]
46. An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions.
Huang MZ; Li HB; Nie XM; Wu XY; Jiang XM
Diagn Cytopathol; 2010 Aug; 38(8):573-8. PubMed ID: 19941368
[TBL] [Abstract][Full Text] [Related]
47. Activation of the retinoblastoma tumor suppressor mediates cell cycle inhibition and cell death in specific cervical cancer cell lines.
Bourgo RJ; Braden WA; Wells SI; Knudsen ES
Mol Carcinog; 2009 Jan; 48(1):45-55. PubMed ID: 18506774
[TBL] [Abstract][Full Text] [Related]
48. Immunoexpression of HPV 16/18 E6 and E7 oncoproteins in high-grade cervical squamous intraepithelial lesions in HIV-positive women.
Rodrigues LC; Speck NM; Focchi GR; Schimidt MA; Marques RM; Ribalta JC
Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909984
[TBL] [Abstract][Full Text] [Related]
49. Perturbation of DROSHA and DICER expression by human papillomavirus 16 oncoproteins.
Harden ME; Munger K
Virology; 2017 Jul; 507():192-198. PubMed ID: 28448850
[TBL] [Abstract][Full Text] [Related]
50. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.
Hirao N; Iwata T; Tanaka K; Nishio H; Nakamura M; Morisada T; Morii K; Maruyama N; Katoh Y; Yaguchi T; Ohta S; Kukimoto I; Aoki D; Kawakami Y
Gynecol Oncol; 2019 Nov; 155(2):340-348. PubMed ID: 31477279
[TBL] [Abstract][Full Text] [Related]
51. The combinational effect of E6/E7 siRNA and anti-miR-182 on apoptosis induction in HPV16-positive cervical cells.
Javadi H; Lotfi AS; Hosseinkhani S; Mehrani H; Amani J; Soheili ZS; Hojati Z; Kamali M
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):727-736. PubMed ID: 29873516
[TBL] [Abstract][Full Text] [Related]
52. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
[TBL] [Abstract][Full Text] [Related]
53. HPV16 oncogene expression levels during early cervical carcinogenesis are determined by the balance of epigenetic chromatin modifications at the integrated virus genome.
Groves IJ; Knight EL; Ang QY; Scarpini CG; Coleman N
Oncogene; 2016 Sep; 35(36):4773-86. PubMed ID: 26876196
[TBL] [Abstract][Full Text] [Related]
54. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
[TBL] [Abstract][Full Text] [Related]
55. E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.
Li L; Xu C; Long J; Shen D; Zhou W; Zhou Q; Yang J; Jiang M
Oncotarget; 2015 Sep; 6(27):23930-43. PubMed ID: 26329329
[TBL] [Abstract][Full Text] [Related]
56. [Expression of Toll-like receptor 4 in cervical cell lines and cervical lesions and its relation to HPV16 infection].
Li Q; Ayshamgul H; Jiang Y; Liu Y; Li G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 38(11):1110-6. PubMed ID: 24316922
[TBL] [Abstract][Full Text] [Related]
57. Vitamin A deficiency in K14E7HPV expressing transgenic mice facilitates the formation of malignant cervical lesions.
Ocadiz-Delgado R; Serafin-Higuera N; Alvarez-Rios E; García-Villa E; Tinajero-Rodríguez M; Rodríguez-Uribe G; Escobar-Wilches DC; Estela Albino-Sánchez M; Ramírez-Rosas A; Sierra-Santoyo A; Hernández-Pando R; Lambert P; Gariglio P
APMIS; 2021 Aug; 129(8):512-523. PubMed ID: 34046932
[TBL] [Abstract][Full Text] [Related]
58. [Study on Dynamic Changes of Human Papillomavirus 16
Li MY; Jian J; Liang KR; Yu JR; Li M; Tang FZ; Li WY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Sep; 50(5):666-671. PubMed ID: 31762235
[TBL] [Abstract][Full Text] [Related]
59. Impact of modulation of telomerase and cancer stem-cell marker OCT4 axis in cervical cancer pathogenesis with underlying HPV16 infection.
Tiwari D; Ray Das C; Sultana R; Kakoti S; Aasif Khan M; Dongre A; Husain SA; Bose PD; Bose S
J Cell Biochem; 2020 Apr; 121(4):2782-2791. PubMed ID: 31692038
[TBL] [Abstract][Full Text] [Related]
60. p16INK⁴a and p14ARF mRNA expression in Pap smears is age-related.
von Keyserling H; Kühn W; Schneider A; Bergmann T; Kaufmann AM
Mod Pathol; 2012 Mar; 25(3):465-70. PubMed ID: 22080060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
